SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029310
Filing Date
2018-11-13
Accepted
2018-11-13 16:11:45
Documents
44
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20180930.htm 10-Q 972686
2 EX-31.1 evok-ex311_6.htm EX-31.1 9599
3 EX-31.2 evok-ex312_9.htm EX-31.2 9871
4 EX-32.1 evok-ex321_8.htm EX-32.1 5085
5 EX-32.2 evok-ex322_7.htm EX-32.2 5268
  Complete submission text file 0001564590-18-029310.txt   3963167

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evok-20180930.xml EX-101.INS 934629
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20180930.xsd EX-101.SCH 32946
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20180930_cal.xml EX-101.CAL 18571
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20180930_def.xml EX-101.DEF 102573
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20180930_lab.xml EX-101.LAB 227680
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20180930_pre.xml EX-101.PRE 172529
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 181178074
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1